AGP Picks
View all

World Politics Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Politics Report.

Press releases published on November 9, 2026

COP31: A new climate reality demands stronger international cooperation
Transgene Reports Continued Clinical Progress  and Q3 2026 Financial Update
Transgene poursuit ses programmes cliniques et fait le point sur sa situation financière au troisième trimestre 2026
ArcelorMittal announces Brad Davey to retire on 1st January 2027
Governor DeWine, Honda, JobsOhio, One Columbus and Union County Announce New Honda Auto Plant to Boost Hybrid Production
Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits
Top Aces Awarded Contract to Deliver Red Air Training for the French Armed Forces
Top Aces remporte un contrat pour assurer des services d’entraînement Red Air au profit des forces armées françaises
STMicroelectronics announces status of common share repurchase program
Kratos Awarded Contract to Deliver Fully Integrated Q/V/Ka-Band Gateway and Antenna Systems for Gulf Space Technology’s Software-Defined Satellite
Greenland Mines Ltd Provides Early Warning Disclosure Regarding AnorTech Inc.
Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network
Transaction in Own Shares
German Institute Apologizes for Nazi Psychiatry, Vindicates Citizens Commission on Human Rights International
GENFIT Highlights Data from Clinical Studies of Nangibotide, Supporting Its Advancement into ACLF with Phase 2 Data Expected in 2027
GENFIT présente les données issues des études cliniques de nangibotide soutenant la poursuite de son développement dans l’ACLF. Résultats de phase 2 attendus en 2027
Valneva Announces Positive Phase 2 Results for Tetravalent Shigella Vaccine Candidate S4V2
Valneva annonce des résultats positifs de phase 2 pour son candidat vaccin tétravalent contre la shigellose S4V2
argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

World Politics Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.